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Current head and neck intensity-modulated radiotherapy (IMRT) techniques cause signiﬁcant toxicity. This may be explained
in part by the fact that IMRT cannot compensate for changes in the location of disease and normal anatomy during treatment,
leading to exposure of at-risk bystander tissues to higher-than-anticipated doses. Adaptive radiotherapy (ART) is a novel approach
tocorrectfordailytumorandnormaltissuevariationsthroughonlineoroﬄinemodiﬁcationoforiginalIMRTtargetvolumesand
plans. ART has been discussed on a conceptual level for many years, but technical limitations have hampered its integration into
routine care. In this paper, we review the key anatomic, dosimetric, and treatment delivery issues at play in current investigational
development of head and neck ART. We also describe pilot ﬁndings from initial clinical deployment of head and neck ART, as well
as emerging pathways of future research.
1.Introduction
Head and neck intensity-modulated radiotherapy (IMRT)
holds promise to provide excellent locoregional control of
head and neck cancer while sparing salivary function and
dose to normal structures [1–3]. IMRT utilizes 3D anatomic
information extracted from imaging acquired several days
prior to treatment. It is recognized that the location, shape,
and size of disease and normal anatomy change signiﬁcantly
due to daily positioning uncertainties and physiological
factorsduringa6-7-weekcourseoftreatment.Thesechanges
include regression of primary tumor and nodal disease,
alterations in normal glands and mucosa, resolution of
postoperative soft tissue eﬀects, and alterations in body
habitus due to weight loss [4–8]. Such changes can be
dramatic. Our group has used serial CT imaging during H
and N treatment to demonstrate that primary tumors can
shrink volumetrically by up to 90% and that parotid glands
can involute and shift medially (towards high-dose coverage
in the oropharynx) by up to a centimeter during a treatment
course [8].
Due to clear dosimetric advantages enjoyed by IMRT
over conventional techniques, the radiation oncology com-
munity has adopted routine use of IMRT for head and
neck cancer in the absence of prospective conﬁrmation of
clinical impact. Only recently has randomized data from
Europe been presented in abstract format (C. Nutting et
al., Proc. ASCO 2009) to demonstrate that IMRT reduces
parotid toxicity, albeit with little beneﬁt beyond this relative
to conventional therapy.
Hands-on experience conﬁrms that IMRT continues to
c a u s es e v e r ea c u t eo r a la n dp h a r y n g e a ls i d ee ﬀects [1–3].
MuchofIMRT’sabilitytoreducetoxicityremainspotentially
unrealized when statically guided by pretreatment imaging.
Treatment failures may also result from unanticipated tumor
movement across critical regions of sharp dose gradient.
There are potential advantages to manual replanning of
IMRT midway through treatment [9], but to date no
prospective clinical study has been performed to demon-
strate the clinical beneﬁts and practicality of this approach.
In addition, the ideal timing for replanning remains an
unresolved issue.2 Journal of Oncology
Adaptive radiotherapy (ART) is an approach to correct
for daily tumor and normal tissue variations through online
or oﬄine modiﬁcation of original IMRT target volumes and
plans. It is a treatment strategy tightly linked to feedback-
based control theory. ART has three basic components: (1)
detection of changes, (2) method of intervention, and (3)
management of overall clinical goals. Successful implemen-
tation of each component determines the overall success
of clinical application. ART is a decades’ old concept, but
technical limitations have held back integration of ART
into routine care. Older ART approaches have depended
largely upon implanted ﬁducial markers or infrequent serial
imagingtoguidelaboriousmanualreplanning.Ideally,direct
staﬀ input must be replaced by automated processes to make
ART practical. Exploratory work [10–12] has demonstrated
the feasibility of ART planning for prostate and H and N
cancer using daily in-room CT image guidance to localize
targets. A prospective clinical trial testing the feasibility of
an automated H and N ART delivery approach at M.D.
AndersonCancerCenteriscurrentlyunderway;initialresults
from this work will be described further below.
2. ClinicalRationales andTypicalTreatment
Approaches for H and N Radiotherapy
One key requirement for IMRT planning is target def-
inition [13–17]. Gross target volume (GTV) determines
the anatomic region which harbors the highest tumor cell
density and requires the highest prescribed dose. Target
deﬁnition is also important to minimize dose to normal
bystander anatomy. Postradiotherapy salivary production is
well predicted by dose-volume eﬀects [18, 19]. Dysphagia
and aspiration are related to irradiated volumes for certain
functional structures [20, 21]. IMRT can potentially allow
clinicianstomeetdeﬁnedparotidanddysphagia-relateddose
constraints and improve objective and subjective measures
of toxicity [1, 2, 22]. However, given that IMRT’s steep
dose gradients couldpotentially move across shifting bound-
aries between neighboring disease and avoidance structures,
meaningful improvements in therapeutic ratio may only be
attained with accurate knowledge of true target locations. As
will be discussed below, lack of updated targeting during a
course of therapy is a likely culprit responsible for continued
issues with treatment toxicity during and following IMRT.
3.Margins and Treatment Designs—Balancing
the Risk andBeneﬁt
Planning target volumes (PTVs) are used to compensate for
treatment setup uncertainties through volumetric expansion
of CTV margins. PTV expansions present dosimetric trade-
oﬀs since these frequently overlap geographically with adja-
cent at-risk normal structures. A favorable therapeutic index
relies on accurate knowledge of setup uncertainties, normal
organ dose tolerances, and delineation of treatment targets
to safely minimize PTV expansions. Questions surrounding
optimal head and neck radiotherapy treatment design and
delivery include the following.
(i) What are the characteristics and kinetics of setup
errors in the H and N region?
(ii) How quickly and by how much can tumor and
normal anatomy change during treatment?
(iii) What are the dosimetric consequences of anatomic
changes and setup errors?
(iv) What is a practical workﬂow template for H and N
ART to compensate for these uncertainties and to
reduce need for PTV expansions?
(v) Is there evidence that ART can be feasibly deployed?
What are the most pressing (or most surmountable)
hurdles impeding future widespread deployment of
clinically meaningful H and N ART?
4.HandNSetupUncertainties
4.1. Baseline Anatomic Uncertainties. Setup uncertainties
relevant to H and N radiation treatment have been actively
investigated [23–30]. Several setup correction protocols have
been proposed to improve corrections for such uncertainties
[31–35] that occur despite the use of custom-ﬁtted ther-
moplastic masks and head rests. With the recent availability
of kV X-rays mounted orthogonally relative to the therapy
beam line, it is possible to acquire high-quality images
for daily image guidance [36]. An advantage of in-room
kV imaging is that it provides images similar to digitally
reconstructed radiographs (DRRs) derived from simulation
CTs. However, this 2D method assumes that anatomic
landmarks are imaged and measured identically across time,
which may not be true.
In-room CT scanners, tomotherapy-based megavoltage
CT, and gantry-mounted cone beam CT are now all avail-
able to provide in-room 3D imaging [37–40]. A unique
requirement for 3D position veriﬁcation is selection of
a region of interest (ROI) to determine shifts relative to
reference simulation images. This process is complicated by
semi-independent movement of the body constituents of
the H and N region. The skull is attached to a semirigid
mandible and to a column of cervical vertebral units with
multiple degrees of movement freedom [41]. Zhang et al.
[42] were the ﬁrst to use in-room CT imaging and serial
3D image registration to analyze the relative movement of
diﬀerent H and N ROIs. Three bony ROIs were deﬁned:
C2 and C6 vertebral bodies and the palatine process of the
maxilla (PPM) as a surrogate for the skull base. Although
ROI movement shifts were highly correlated to a clinical
isocenter marked on the immobilization mask, displacement
uncertainties of up to 2–6mm were observed between any
two ROIs, indicating the eﬀects of ﬂexibility and rotation
on position uncertainty. In a more recent study [43], eight
ROIsweredeﬁnedandanalyzedin38patientswhohadserial
cone-beam CT imaging taken during treatment. Diﬀerent
subregionswereshowntomovediﬀerentlyduetodiﬀerential
ﬂexion across regions. Local residual errors ranged up to
3.4mm (one standard deviation), translating to a need for
4–7mm PTV margin expansions even despite daily image
guidance.Journal of Oncology 3
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Figure 1: The positions of the hyoid and thyroid cartilages can change noticeably during the simulation or treatment delivery. Because the
swallowing action is usually infrequent and has a short duration, a simulation CT could be biased towards an infrequent anatomical pose
by the consequence of swallowing. If the hyoid and thyroid cartilages are captured at their most inferior positions (top row), the larynx
may receive higher dose during treatment. In the converse situation, if the hyoid and thyroid cartilages are captured at their most superior
positions during CT simulation (bottom row), a primary target near the base of tongue could be underdosed during treatment.
The site of the largest systematic setup uncertainty in
H and N region is the larynx, emphasizing the importance
of internal motion secondary to swallowing and tongue
movement. Unfortunately, such internal movement cannot
be directly addressed in patients (at least not comfortably).
Because the larynx and tongue are attached to the hyoid
bone, tongue movement may result in displacement of the
larynx. Inspiration and expiration also causes displacement
ofthelarynx,althoughthisdisplacementisusuallymodestat
rest. Videoﬂuoroscopy can demonstrate 20–25mm cranial-
caudal and 3–8mm anterior-posterior laryngeal movement
during swallowing of liquid [44–46]. Fortunately, the pro-
portional duration of active swallowing is low and does not
appear cause dosimetric deviations during treatment [47].
Work at M.D. Anderson Cancer Center has investigated
internal systematic and random errors caused by swallowing
using a fast helical CT scanner (CT-on-Rails), measuring the
position of the thyroid cartilage relative to that of the hyoid
bonein17oropharyngealcancerpatients.Atotalof555daily
CTs were taken (30–33 images/patient). These structures
were found to move up to 1.6cm during a treatment course
relativetovertebrallandmarks,mostnotablyinthesuperior-
inferior (SI) direction. Systematic errors relative to baseline
position from simulation for individual patients were large
(up to 12mm). The clinical signiﬁcance of this error is
illustrated in Figure 1. Because swallowing is infrequent
and has a short duration (∼1 second), its intrafractional
dosimetric eﬀect is less critical than its systematic impact.
For example, a fast simulation CT could be heavily biased by
an infrequent anatomical pose if obtained mid-swallow. In
such an instance, the larynx may receive higher dose during
treatment if the hyoid bone and neighboring oropharyngeal
sitestargetedforhighdoseareinadvertentlycapturedattheir
most inferior position (top row). In an opposite situation, if
the hyoid and thyroid are captured at their most superior
position during CT simulation (bottom row), a primary
target near the base of tongue could be underdosed during
treatment.
4.2. Anatomic Uncertainties Occurring during Treatment.
Some patients receiving radiation therapy to the head and
neck region will have signiﬁcant anatomic changes during
their course of treatment, including shrinking primary
tumors or nodal masses, resolving postsurgical edema, and
weight loss [4–7]. An example of such a case is shown
in Figure 2. This illustrates how common on-treatment
anatomical changes render an original IMRT plan to be less
conformal than its original intent.
Barker et al. [8] used serial in-room CT imaging to
study gross tumor volume (GTV) changes during a complete
treatment course. CT scans were acquired three times weekly
in 14 patients. Manual contouring was used to evaluate GTV
changes.GTVdecreasedthroughouttherapyatamedianrate
of0.2ccpertreatmentday(range,0.01–1.95cc/day).Figure3
shows the volume change for primary tumors and lymph
nodes. It was found that both primary tumors and involved
lymph nodes lost volume at approximately the same rate of
1.7%-1.8% per treatment day. On the last day of radiation
treatment, this corresponded to a median total relative loss
of approximately 70% of the initial GTV (range, 10%–92%).
Rate of volume loss was strongly associated with the baseline
target volume, a relationship which could help to identify4 Journal of Oncology
Planning CT During treatment
Figure 2: Anatomic changes can be pronounced during treatment. In this example, planning CT scan and CTV contours are shown on the
left. On the right, a mid-course CT (three weeks into treatment) demonstrates signiﬁcant reduction in gross tumor (thick red line). Baseline
CTVs have been overlaid via rigid image registration. These match current anatomy poorly and in fact extend past the skin contour into air.
candidate patients who may beneﬁt most from an adaptive
radiotherapy approach.
Parotid glands also involute during therapy (Figure 4).
Barker et al. observed that the median parotid volume loss
was 0.2cc/day or 0.6%/day of the initial volume. At the
end of treatment, median parotid volume loss was 28.1%.
The center of mass of both parotid glands shifted medially
over time. By the end of treatment, this medial shift was
3.1mm (range: −0.3–9.9mm). Lee et al. acquired similar
data using daily megavoltage CT imaging [48]. Day-to-day
variations in the center-of-mass distance and volume were
1.61mm and 4.36%, respectively. Parotid volumes decreased
with a median total loss of 21.3% and a median change rate
of 0.7%/day. Parotids migrated toward the patient center
with a median total distance change of −5.26mm (0.00 to
−16.35mm) and a median change rate of −0.22mm/day.
Another CT-based study of 82 head and neck cancer patients
showed an average volume loss in parotid glands of 20.0%,
26.9%, and 27.2% after 3-week mid-treatment, at treatment
completion, and 2-month posttreatment, respectively [49].
These gland volume reductions correlated signiﬁcantly with
mean dose to the irradiated glands: volume loss with
higher mean parotid doses (>30Gy) to the glands was
signiﬁcantly greater than for lower mean parotid doses
(P<. 001).
Finally, nearly all patients lost weight throughout their
course of treatment. Barker et al. found that the median
weight change from the start to completion of treatment was
–7.1% (range, +5.2% to –13.0%) in their study. Reductions
in external skin contours at the level of the C2 vertebral body
and at the base of skull correlated with weight loss. Median
weight loss correlated signiﬁcantly with median parotid
medial displacement over time (P<. 001). This conﬁrms
that skin contours and weight loss can potentially be
used as easy-to-measure harbingers of underlying anatomy
changes.
5. Image-GuidedAdaptive Radiotherapy for
HandNCanc e r
5.1. Image-Guided Approaches for H and N Radiotherapy.
The term image-guided radiation therapy (IGRT) is com-
monly interpreted as the use of in-room imaging to make
setupcorrections,inparticular,positionalshifts.Imageguid-
ance does not typically involve modiﬁcation of the original
treatment plan, which means that IGRT aims at correction
of setup errors and reducing CTV-to-PTV margin. Although
there are other approaches for H and N patient setup, in-
room stereoscopic and volumetric imaging are the most
commonly used techniques for IGRT.
IGRT workﬂow for H and N patients is not diﬀerent
from other treatment sites, with the notable exception
that an ROI should be explicitly identiﬁed by the treating
physician as a part of patient’s treatment directive. Previous
s t u d i e sh a v ep r o v i d e ds u ﬃcient evidence that the relative
movement of diﬀerent ROIs can be signiﬁcant in the H
and N region. Ignoring these diﬀerences in diﬀerent regions
would introduce additional setup uncertainties [36, 43]. The
selection of ROI depends on the treatment case, which is
a balance between target coverage and normal structure
sparing. Typically, the spinal cord sparing is critical for
most H and N cases; therefore, a vertebral body is generally
a good choice as a reference ROI for alignment. For an
oropharyngeal cancer case, a high cervical (C1–C3) vertebral
body is a reasonable choice (Figure 5). Although a PTV
can be used in particular cases, one should be cautious
using GTV as an alignment target since asymmetric tumor
shrinkage can aﬀect the geographic relationship of GTV to
isocenter and avoidance structures.
5.2. Anticipated Workﬂow for Image-Guided Adaptive Radio-
therapy. In contrast to image-guided setup for repositioning
treatment ﬁelds, the intent of ART is to appropriately modifyJournal of Oncology 5
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Figure 3: Gross tumor volume changes over time among patients with head and neck cancers. Both primary tumor (a) and (b) and lymph
nodes greater than 2cc of volume (c) and (d) are showing similar trend. The gross tumor volumes decreased at a median rate of 0.2cc or
1.8% of initial volume per treatment day. (Reprinted from [8]).
a radiation treatment plan to account for temporal changes
in anatomy. In theory, ART can occur at three diﬀerent
timescales: oﬄine between fractions, online immediately
prior to a fraction, and in real-time during a treatment
fraction. ART can be tightly linked to image guidance
processes because any volumetric images acquired for IGRT
procedure could also be used for monitoring changes in
anatomy and designing new plans.
An example of ART workﬂow is shown in Figure 6.D a i l y
in-room volumetric imaging is essential to both the IGRT
and ART pieces of this workﬂow. Solid lines indicate the
image-guidance procedure controlling the position of the
treatment couch. Volumetric images can be simultaneously
sent to a treatment planning system where a new treatment
plan can be adapted to current anatomy via automated
deformableregistrationsoftwareandsentbacktothetherapy
machine for delivery. This is shown in dotted lines in
the procedure workﬂow. The adapted plan could be either
deployed immediately (online correction) or used for future
treatment (oﬄine correction).6 Journal of Oncology
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Figure 4: A case example of changes in parotid gland volume during a 33-fraction IMRT treatment course. (a) shows the percent of volume
change for each parotid as a function of treatment fraction. The (b) and (c) shows an axial CT slice of the parotid before radiotherapy (b)
and after 33 fractions of radiotherapy (c).
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Figure 5: Region-of-interest (ROI) selection for H and N IGRT should be based on clinical goals and is ideally located in proximity to
critical clinical target volumes and/or normal structures requiring strict sparing. The top row shows a base-of-tongue cancer in which the
C2 vertebral body was selected as an alignment object close to both GTV and spinal cord. For a sinus cancer case (bottom row), the PTV was
used as the alignment ROI for patient setup to optimize coverage of high-risk CTVs and sparing of closely neighboring neural tissues.
5.3. Deformable Image Registration for Autosegmentation.
Manual segmentation of treatment planning images
demands too much physician and staﬀ eﬀort to be practical
for routine deployment of ART. Manual contouring would
also be susceptible to intra- or interobserver variations
[50], which could adversely aﬀect the consistency of
treatment quality. Deformable image registration for
atlas-based autosegmentation is an eﬀective alternative for
serial adaptive replanning [14, 51–55]. Deformable image
registration is a geometric mapping process that createsJournal of Oncology 7
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Figure 6: A workﬂow diagram for in-room CT or CBCT-guided adaptive radiotherapy. The ﬁrst level of treatment modiﬁcation is a simple
couchshifttocorrectfordailysetuperrors(CT-guidedIGRT).Nonrigidchangesintumorvolumesandnormalorganscanthenbecorrected
via an online or oﬄine adaptive replanning process (dotted lines).
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Figure 7: The ART process for patient treatment starts with a rigid alignment (in this example, to the C2 vertebra) between the reference
planning CT and the daily in-room CT ((a) and (b)). The planning contours are overlaid to the daily CT to verify setup accuracy and to
evaluate if there are changes in current anatomy relative to baseline. If the changes are signiﬁcant, as illustrated in (b), a deformable image
registration can be performed to propagate original planning contours onto current anatomy. The resultant contours are shown on (c). This
process takes less than 30 seconds.8 Journal of Oncology
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Figure 8: An example of serial ART dose recalculation using a daily CT image acquired at the 25th treatment fraction. On (a), the original
plan is calculated on current anatomy. The original plan provides inappropriate treatment margins and dose heterogeneity within the high-
dose CTV. In the (b), an earlier ART replan (ART1, designed at the 15th treatment fraction) is calculated onto current anatomy. On (c), a
2nd ART replan (ART2) is designed and calculated for the current daily image set. The ART2 plan provides improved contralateral parotid
sparing and a lower total body dose than the ART1 plan.
one-to-one correspondence between two images of the same
object deformed across time. If the contours exist in one of
the reference CT images, deformable transformation can
be used to transform reference contours onto the newly
acquired CT images with minimal manual input. This is well
suited for ART, given that the original treatment plan can
serve as the reference for this process.
An example of using deformable image registration for
autosegmentation is shown in Figure 7. The process starts
with a rigid alignment of bony structure (C2 vertebra)
between the reference planning CT (left) and the daily
in-room CT (middle and right). The necessary planning
contours are overlaid onto the daily CT to verify setup
accuracy and to ascertain whether signiﬁcant anatomic
changes have occurred at interval. If the changes are
signiﬁcant (for example, the original clinical target volumes
no longer adequately cover gross disease visualized on
daily CT images), deformable image registration can be
performed to propagate the planning contours to the daily
anatomy. The resultant contours are shown to the right. The
entire transformation takes seconds, making it relevant to
either online or oﬄine IMRT replanning. Manual physician
recontouring can take several hours [14], which would not
be practical for online ART and would strain practical
application of oﬄine ART.
5.4. Dosimetric Beneﬁts of H and N ART. With deformable
image registration for dose accumulation, it is possible to
evaluate uncorrected IMRT relative to IGRT or full ART.
O’Daniel et al. [56] studied the diﬀerences between planned
and delivered parotid gland and target doses in a group
of H and N cancer patients receiving standard IMRT. The
clinical IMRT plans, designed with 3 mm to 4 mm PTV
margin expansions, were recalculated on the repeated CT
images. Deformable image registration software was used to
map daily dose distributions to the original treatment plan
and to calculate a cumulative delivered dose distribution.
Without IGRT, dose to the parotid gland increased above
the planned dose by 5–7Gy in 45% of the patients. Use
of IGRT aligned to the C2 vertebral body provided modest
but signiﬁcant parotid dose reductions in 91% of patients
(median, 2Gy). Nonetheless, the parotid dose from bone
alignment remained greater than planned doses (median,
1.0Gy, P = .007) due to parotid shrinkage and movement.
Using daily MV imaging in 10 tomotherapy patients,
Lee et al. analyzed changes in parotid gland dose using a
deformableimage registration method [57]. They found that
the daily parotid mean dose of the 10 patients diﬀered from
the plan dose by an average of 15%. At the end of treatment,
3 of the 10 patients were estimated to have received a greater
than 10% higher mean parotid dose than in the original plan
(range, 13%–42%). Dose diﬀerences correlated with medial
drifting of the parotids toward the high-dose region.
Wu et al. performed a comprehensive adaptive replan-
ning simulation study to evaluate the diﬀerences between
planned and delivered doses and to investigate diﬀerent
replanning strategies [58]. Eleven patients underwent six
weeklyhelicalCTsduringroutineIMRT.Cumulativedosesto
CTVs were preserved even with use of 0 mm PTV expansion
margins. Signiﬁcant increases in parotid dose were observed
without adaptive replanning. The authors reported that one
adaptive replanning during midcourse improved parotid
mean dose sparing by 3%, two replannings by 5%, and
six replannings by 6%, assuming that adaptive replanning
transpires one week prior to actual treatment delivery. If six
weekly replans are used immediately, parotid dose sparing
is improved 8%. However, these calculations assumed that
each new plan is executed without additional setup errors or
nonrigid changes.
5.5. Clinical Experience with Automated H and NA R T .Is
automated H and N ART feasible, and what is its clinical
impact? At M.D. Anderson Cancer Center a prospective, IRB
approved clinical trial is underway to test these questionsJournal of Oncology 9
in oropharyngeal cancer patients treated with deﬁnitive
IMRT. Patients with locally advanced AJCC stage III-IV
disease are eligible for inclusion. Baseline IMRT planning
follows standard guidelines, with volumetric CTV-to-PTV
expansions of 3-4mm. In-room CT-guided IGRT is used for
each treatment session. This rigid alignment step corrects
for any setup errors based on the bony landmark of cervical
vertebrae in the C1–C3 region. Attending physicians have
the chance to evaluate each daily IGRT setup. If signiﬁcant
anatomic changes resulting in geographical miss of gross
tumor or inadequate sparing of normal tissues (particularly
parotid glands or larynx) are noted by a physician triaging
the daily CT images, then formal dosimetry and planning
evaluations are instigated. Deformable image registration is
performed with a validated in-house version of Thirion’s
Demons algorithm [52] which is used to transfer the initial
contours (GTV, CTV, parotid, spinal cord, brainstem, and
other normal structures) to the new CT image set. In
addition to contours, isocenter information and the original
IMRT plan are loaded into a new plan based on the newly
acquired CT image set. A copy of this baseline plan is
made, and a new updated plan can then be designed based
on current anatomy. Additional planning constraints may
be added to improve the quality of the new plan on an
individualized basis.
It is important to emphasize that this trial does not
employ PTV expansions for adaptive replanning. Our pilot
experience has conﬁrmed highly precise treatment setup
reproducibility with our CT-guided IGRT procedure once
patients have acclimated to treatment. Additional experience
hasconﬁrmedthatstandard3-4mmPTVexpansionmargins
are too generous to maintain parotid dose sparing if daily
image guidance is employed [56]. Other than an absence
of PTV expansions, ART planning does not diﬀer from
standard IMRT planning practice. Therefore, the intent for
ART is to recapitulate the treatment planning goals of the
original IMRT plan as faithfully as possible, rather than to
create novel planning guidelines.
An example of ART dose recalculation and replanning
is shown in Figure 8. Figure 8(a), the original plan is
calculated onto current anatomy. Due to loss of weight and
tissue separation, there is less attenuation of each IMRT
beam. As a result, the original plan provides inappropriately
large treatment margins and considerable dose heterogeneity
within the high-dose CTV. Figure 8(b), a previous ART
replan(ART1,designedatthe15thtreatmentfraction)iscal-
culated onto current anatomy. The ART1 replan signiﬁcantly
improves dose conformality because PTV expansions are not
used. Figure 8(c), a 2nd ART replan (ART2) is designed
and calculated for the current daily image set. The ART2
plan provides further improvement of contralateral parotid
sparing and a lower scattered body dose relative to the ART1
plan.
A preliminary analysis of 724 daily CT images in 22
patientswhohavecompletedafullcourseofARTfororopha-
ryngeal cancer has been performed. The cohort consisted
of 20 males and 2 females, with a median age of 58 years
(range: 51–77). Primary disease site was base of tongue in 15
patients and tonsil in 7 patients. Nineteen patients had AJCC
stage IV disease while 3 were of stage III. T stage distribution
was 3 T1, 10 T2, 5 T3, and 4 T4 and N stage distribution
was 3 N0, 2 N1, 3 N2a, 12 N2b, and 2 N2c. By treatment
completion, mean parotid shrinkage was 26%, consistent
withouroriginalpublishedﬁndings[8].Allpatientsreceived
at least one replan and 8 patients (36%) received two replans
during their course of treatment. As illustrated in Figure 9,
we compared 4 planning scenarios: (1) the original IMRT
plan aligned to the marked isocenter (BB), (2) the original
plan aligned according to daily bone alignment (IGRT),
(3) IGRT with one adaptive replan (ART1), and (4) actual
treatment received by each study patient (IGRT with either
one or two adaptive replans, ART2). As summarized in
Figure 10, the median trigger point for the ﬁrst adaptive
replanning was the 16th treatment fraction (range: 2 to 28),
at which point combined parotid volumes had shrunk by
15% and combined CTVs had shrunk by 4% (see Figure 11
for a case example). For ART2 patients, the median trigger
points for the ﬁrst and second replanning were the 11th
and the 22nd fractions, respectively. In retrospective dose
analysis, ART1 group (16 cases) reduced the mean dose to
contralateral parotid by 0.6Gy or 2.8% (P = .003) and
ipsilateral parotid by 1.3Gy (3.9%) (P = .002) over the
IGRT-only group. ART2 (4 cases) further reduced the mean
contralateral parotid dose by 0.8Gy or 3.8% (P = .026) and
ipsilateral parotid by 4.1Gy or 9% (P = .001). ART also
signiﬁcantly reduced integral body dose at 60Gy and 40Gy
levels compared to IGRT alone.
Thistrialistheﬁrstprospectivedemonstrationofthefea-
sibility of adaptive head and neck radiotherapy. Signiﬁcantly,
initial results suggest that conventional IGRT alone does
not provide meaningful dosimetric beneﬁt if conventional
PTV margins are used. One properly timed adaptive replan
(ART1) appears to provide the most relevant dosimetric
improvements. The study is ongoing and continues to
correlate clinical outcomes to these dosimetric results.
6. FutureDirections for
ART Reﬁnement and Deployment
6.1. Online Versus Oﬄine Adaptive Radiotherapy. Online
ART adjusts the treatment plan daily in real time using
images acquired during each treatment session. An oﬄine
approach,ontheotherhand,usesimaginginformationfrom
a previous time point for planning changes incorporated
into a subsequent treatment session. The online approach
can potentially provide greater treatment precision, at the
cost of increased daily eﬀort and treatment time. It is
more challenging due to uncompromising time constraints
(the patient remains immobilized on the treatment couch
while waiting for ART corrections). In the case of H and
N radiation treatment, most anatomic changes take place
gradually over the ﬁrst few weeks of therapy. There is no
need for real-time intervention unless an acute, unforeseen
event occurs, such as rapid disease progression. Therefore,
in our opinion, oﬄine adaptive radiotherapy appears to be a
more practical approach for H and N cancer in the majority
of cases, which should make ART easier to deploy across the
practicing radiation oncology community.10 Journal of Oncology
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Figure 9: An example of cumulative dose evaluation for IMRT treatments without daily image guidance (alignment to the surface markers
or “BBs”on the immobilization device) (BB-IMRT), image-guided IMRT (IG-IMRT), and image-guided adaptive IMRT described in this
investigation (adaptive IMRT). Due to setup error, BB-IMRT has a tendency to underdose CTV.
6.2. Correction for Nonrigid Setup Error. In H and N radio-
therapy patients, it is common for spinal anatomy to exhibit
complex, nonrigid geometric changes that can aﬀect treat-
ment plan conformality. If these nonrigid changes are sys-
tematic (i.e., caused by impropriate simulation procedures),
adaptive replanning can be used to correct these nonrigid
systematic setup errors even if tumor target volumes have
not changed. Our experience showed that random nonrigid
setup errors are diﬃcult to correct. Resetting patient’s setup
position usually does not fully correct these errors. In special
cases (i.e., retreatment of areas close to critical structures,
such as central nervous tissues) where desired accuracy
requires daily real-time correction of random (nonrigid)
setup error, online ART may become desirable.
6.3. Auto-Replanning. For all current ART strategies, replan-
ning remains a time-consuming process. It will be necessary
to reduce resource requirements for ART through eﬀective
automated planning techniques. Although replanning bene-
ﬁts from information provided by initial planning, trial-and-
error is still necessary to ﬁne-tune planning parameters for
optimization. Several groups have studied auto-replanning
algorithms. In almost all cases, deformable image registra-
tion is a critical component of this process. Mohan et al.
[10] used an IMRT intensity warping technique to adapt
an IMRT plan based on the changes in the anatomy in the
beam’s-eye-view projection. This proof-of-principle study
demonstrated that autoplanning was possible and could
emulate the quality of manual treatment planning. However,
a deformed intensity map may not always be clinically
deliverable. To reduce the likelihood for such a possibility,
Ahunbay et al. [59] proposed a more sophisticated two-
step procedure for auto-replanning. The ﬁrst step uses
an aperture morphing technique to transform MLC leaf
segment based on anatomy changes. The second step applies
a segment weight optimization, which reoptimizes the entire
plan. The entire process takes 5–8 minutes, conﬁrming
the potential feasibility of such an approach. Continued
improvement of auto-replanning, therefore, promises to
make routine online adaptive radiotherapy a possibility. It
may also reduce manual workload requirements for oﬄine
ART as well.
7. Conclusions
Feasible adaptive radiotherapy has long been a clinical goal.
Current adaptive radiotherapy strategies remain labor and
resource intensive. However, initial results from prospectiveJournal of Oncology 11
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Figure 10: A histogram plot of the timing of the triggering fraction for replanning for the 1st replan and 2nd replan.
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a patient who had two replans performed during the course of treatment. The ﬁrst replan occurred at the 9th treatment fraction, and the
second replan was designed at the 23rd treatment fraction.
clinical trial work employing automated deformable image
registration demonstrate the feasibility and dosimetric bene-
ﬁt from use of head and neck adaptive radiotherapy. As ART
clinical outcomes mature and incorporation of volumetric
imaging into ART becomes increasingly sophisticated, we
expect ART to evolve briskly towards becoming a com-
monplace approach for head and neck radiation treatment.
Nonetheless, the optimal frequency and utilization as well as
the ultimate clinical impact of ART remain undeﬁned, and
prospective clinical trials will be necessary to appropriately
mold ART into a future treatment standard.
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